Insights / Awards

Clinion has been recognized with the 2024 Technology Innovation Leadership Award by Frost & Sullivan its pioneering role in transforming clinical trials. This award reflects our ability to bridge industry gaps and deliver end-to-end solutions that empower study teams, streamline operations, and redefine what’s possible in clinical research with AI.
Clinion’s platform brings together Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), Randomization and Trial Supply Management (RTSM), and Electronic Patient-Reported Outcomes (ePRO) in a single, integrated environment. This consolidation allows teams to manage all aspects of a trial from one place, reduces manual coordination, and supports studies of any scale, from early-phase trials to global, multi-year programs.
AI and automation are embedded across the platform to enhance operational efficiency. Features like automated Protocol generation, AI-assisted medical coding, remote SDV (rSDV), and CSR automation reduce repetitive tasks and improve data accuracy, helping teams focus on critical decision-making.
Clinion is designed for rapid deployment and intuitive use. Global libraries and pre-configured templates allow teams to set up studies quickly, while mid-study updates can be applied seamlessly, minimizing disruptions and keeping trials on track.
This recognition underscores Clinion’s ability to deliver practical solutions that address real-world challenges in clinical research. By making trial management faster, simpler, and more reliable, Clinion is setting a new standard for efficiency and operational excellence in the industry.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance

